tiprankstipranks
Advertisement
Advertisement

TEVA Stock Latest News

Teva price target raised to $48 from $42 at UBS
The FlyTeva price target raised to $48 from $42 at UBS
20h ago
TEVA
Teva Advances NYSE Listing With ADS Exchange Plan
PremiumCompany Announcements
Teva Advances NYSE Listing With ADS Exchange Plan
1d ago
8K
TEVA
Teva Recasts Segments to Support Pivot to Growth
PremiumCompany Announcements
Teva Recasts Segments to Support Pivot to Growth
1d ago
8K
TEVA
Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer
PremiumThe Fly
Vaxcyte names Luis Jodar chief medical officer, David McAvoy chief legal officer
1d ago
PFE
PCVX
J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential
PremiumRatings
J.P. Morgan’s Salveen Richter Reiterates Buy on Teva, Citing TEV-408 Phase 2a Success and Pipeline-in-a-Product Potential
2d ago
TEVA
Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data
PremiumRatingsTeva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data
3d ago
TEVA
Morning Movers: Dell rises, G-III Apparel falls after earnings
Premium
The Fly
Morning Movers: Dell rises, G-III Apparel falls after earnings
3d ago
CXM
VRT
Teva reports TEV ‘408 study met primary endpoint
Premium
The Fly
Teva reports TEV ‘408 study met primary endpoint
3d ago
TEVA
Teva to lower cost of select medicines for American patients covered by Medicaid
PremiumThe Fly
Teva to lower cost of select medicines for American patients covered by Medicaid
4d ago
TEVA
Etsy, ConocoPhillips, Intuit, Teva, Rithm: Insider Cashouts
PremiumWeekend Updates
Etsy, ConocoPhillips, Intuit, Teva, Rithm: Insider Cashouts
7d ago
COP
ETSY
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
PremiumThe Fly
Teva unit bids to acquire neuroscience product from BioXcel Therapeutics
8d ago
BTAI
TEVA
BioXcel Therapeutics enters asset sale agreement with Teva
PremiumThe Fly
BioXcel Therapeutics enters asset sale agreement with Teva
8d ago
BTAI
TEVA
Aurinia settles patent litigation with Teva
PremiumThe FlyAurinia settles patent litigation with Teva
16d ago
AUPH
TEVA
TEVA Stock Climbs as 50-Year-Long Tourette Syndrome Drug Breakthrough Moves Closer
Premium
Market News
TEVA Stock Climbs as 50-Year-Long Tourette Syndrome Drug Breakthrough Moves Closer
17d ago
TEVA
Teva announces FDA acceptance of ecopipam NDA
Premium
The Fly
Teva announces FDA acceptance of ecopipam NDA
17d ago
TEVA
Teva price target raised to $42 from $40 at Barclays
PremiumThe Fly
Teva price target raised to $42 from $40 at Barclays
19d ago
TEVA
Teva call volume above normal and directionally bullish
PremiumThe Fly
Teva call volume above normal and directionally bullish
19d ago
TEVA
Teva: Buy Rating Reiterated as Analyst Sees Listing and Pipeline Upside, Keeps $42 Price Target Unchanged
PremiumRatings
Teva: Buy Rating Reiterated as Analyst Sees Listing and Pipeline Upside, Keeps $42 Price Target Unchanged
29d ago
TEVA
AI Models Turn More Constructive on Teva Pharmaceutical (TEVA) as Earnings and Margins Improve
PremiumAI Analyst Ratings
AI Models Turn More Constructive on Teva Pharmaceutical (TEVA) as Earnings and Margins Improve
1M ago
TEVA
Teva Earnings Call Highlights Innovative Growth Shift
PremiumCompany AnnouncementsTeva Earnings Call Highlights Innovative Growth Shift
1M ago
TEVA
Morning Movers: Generac, Amphenol climb following earnings
Premium
The Fly
Morning Movers: Generac, Amphenol climb following earnings
1M ago
F
V
Teva says ‘clear path’ to 30% operating margin by 2027
Premium
The Fly
Teva says ‘clear path’ to 30% operating margin by 2027
1M ago
TEVA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >